| 000 | 01529 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513220902.0 | ||
| 264 | 0 | _c20001004 | |
| 008 | 200010s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/jvi.74.19.9028-9038.2000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNousbaum, J | |
| 245 | 0 | 0 |
_aProspective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. _h[electronic resource] |
| 260 |
_bJournal of virology _cOct 2000 |
||
| 300 |
_a9028-38 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xadministration & dosage |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 |
_aViral Nonstructural Proteins _xgenetics |
| 700 | 1 | _aPolyak, S J | |
| 700 | 1 | _aRay, S C | |
| 700 | 1 | _aSullivan, D G | |
| 700 | 1 | _aLarson, A M | |
| 700 | 1 | _aCarithers, R L | |
| 700 | 1 | _aGretch, D R | |
| 773 | 0 |
_tJournal of virology _gvol. 74 _gno. 19 _gp. 9028-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/jvi.74.19.9028-9038.2000 _zAvailable from publisher's website |
| 999 |
_c10929620 _d10929620 |
||